rs4977574 — CDKN2B-AS1 9p21.3

ANRIL's Second Voice — The 9p21.3 Independent CAD Signal at rs4977574

The 9p21.3 locus on chromosome 9 is the most robustly replicated genetic risk region for coronary artery disease ever identified, and rs4977574 is one of its key sentinels. Located within an intron of CDKN2B-AS1 — the gene encoding ANRIL¹¹ ANRIL
Antisense Non-coding RNA in the INK4 Locus, a long non-coding RNA that epigenetically regulates the p16/p15 cell-cycle-inhibitor cluster — this variant captures a partially independent signal from the well-known rs1333049, with the two SNPs sharing an r² of approximately 0.89 in European populations. Together they provide better CAD risk stratification than either alone.

The G allele at rs4977574 is carried by approximately 47% of people of European and East Asian ancestry, but only 18% of those of African descent. This frequency means that roughly 72% of Europeans carry at least one G allele — making this one of the most common high-impact cardiovascular risk variants in the genome.

The Mechanism

ANRIL is a 3,834 bp long non-coding RNA that spans the 9p21.3 region and functions as a master regulator of the CDKN2A/CDKN2B gene cluster. It recruits Polycomb repressive complexes PRC1 and PRC2²² Polycomb repressive complexes PRC1 and PRC2
Large chromatin-modifying protein complexes that silence genes by adding repressive histone marks (H3K27me3) to their promoters to silence p16-INK4a and p15-INK4b in vascular smooth muscle cells (VSMCs) and macrophages, keeping these cells in a proliferative, repair-competent state rather than entering cellular senescence.

The 9p21.3 risk haplotype tagged by rs4977574 disrupts enhancer elements within ANRIL's regulatory architecture. This impairs the ANRIL–Polycomb axis, allowing premature de-repression of p16 and p15 in vascular tissue — accelerating VSMC senescence, impairing vascular repair capacity, and promoting the pro-inflammatory senescence-associated secretory phenotype (SASP) that drives atherosclerotic plaque vulnerability.

A secondary mechanism operates through an interferon-γ–STAT1 pathway³³ interferon-γ–STAT1 pathway
Risk SNPs at 9p21 disrupt a STAT1 binding site at an IFN-γ-responsive enhancer, altering expression of ANRIL and nearby genes in response to immune stimulation, contributing to vascular inflammation independent of the senescence pathway. The G allele's direct effect on lipid metabolism is also documented: GG carriers show higher total cholesterol, elevated LDL-C, and reduced HDL-C independently of other risk factors.

The Evidence

The variant's CAD association is established across multiple independent datasets. The Malmö Diet and Cancer Study⁴⁴ Malmö Diet and Cancer Study
Prospective cohort, 23,949 individuals, 15 years of follow-up, 3,164 incident CVD events genotyped rs4977574 as the primary 9p21.3 SNP and found each G allele was associated with a 16% increased incidence of cardiovascular disease (HR 1.16; 95% CI 1.10–1.22). This prospective data, independent of retrospective studies, is particularly strong evidence.

A 2021 meta-analysis of 17 studies covering 40,979 subjects⁵⁵ 2021 meta-analysis of 17 studies covering 40,979 subjects
Li & Wang, Journal of Cellular and Molecular Medicine confirmed the G allele as a CHD risk factor under multiple genetic models (allelic OR 1.18; homozygous OR 1.39; recessive OR 1.36). An earlier Asian-specific meta-analysis of 12,005 subjects across 6 studies⁶⁶ Asian-specific meta-analysis of 12,005 subjects across 6 studies
Xu et al., Medicine 2018 found allelic OR 1.18 (p = 0.010) and GG vs AA OR 1.46 (p = 0.002).

What makes rs4977574 especially actionable is the documented gene-diet interaction. In a Hispanic case-control study of 3,311 individuals⁷⁷ Hispanic case-control study of 3,311 individuals
1,560 MI cases and 1,751 controls from Costa Rica — which used rs4977574 as its primary genotyped 9p21 SNP — a striking interaction with sugar-sweetened beverage (SSB) intake was identified: the per-allele OR for MI was 1.44 in those consuming more than 2 SSB servings per day, 1.21 at 1–2 servings/day, and a non-significant 0.97 in those consuming fewer than 1 serving per day (P-interaction = 0.005). The Malmö cohort separately found that vegetable intake interacts with rs4977574 to modify both CVD incidence and metabolic markers including HbA1C.

Practical Actions

For G-allele carriers, the most specific and actionable interventions are:

Eliminate sugar-sweetened beverages. The SSB–rs4977574 interaction is particularly strong and was identified with rs4977574 as the primary SNP. This is a genotype-directed intervention: the same SSB consumption that mildly elevates risk in the general population can amplify risk by 44% per G allele in high consumers.

Maximize vegetable intake. The Malmö cohort found that the G allele's association with elevated HbA1C was restricted to those in the lowest tertile of vegetable intake; higher vegetable intake was associated with lower HbA1C specifically among AG and GG carriers. The INTERHEART/FINRISK data (using proxy SNPs) showed raw vegetable and fruit intake dose-dependently attenuated MI risk from the 9p21 haplotype.

Monitor lipids from an early age. The G allele independently raises LDL-C and total cholesterol while reducing HDL-C. This lipid-altering effect stacks with the plaque-forming mechanism, making annual fasting lipid panels a genotype-specific monitoring priority from age 35.

Consider CAC scoring. Coronary artery calcium scoring detects subclinical atherosclerosis — the primary tissue-level consequence of 9p21.3 risk — and is an appropriate screening tool for G-allele carriers to guide statin therapy decisions.

Interactions

rs4977574 shares its 9p21.3 risk haplotype with rs1333049 (r² ≈ 0.89 in Europeans), rs10757278, and rs10757274. These SNPs largely capture the same biological signal through ANRIL dysregulation. However, rs4977574 is the SNP most consistently used in gene-diet interaction studies of this locus — the SSB interaction (PMID 26961926) and the Malmö vegetable/wine interaction (PMID 25551366) were both conducted with rs4977574 as the primary genotyped variant. Together with rs1333049, the two SNPs refine risk stratification beyond what either captures individually; individuals with risk alleles at both loci carry greater burden than either prediction alone.

The 9p21.3 locus shows a documented interaction with telomere length⁸⁸ telomere length
Short telomeres combined with 9p21 risk alleles are associated with compounded adverse cardiovascular outcomes beyond either factor alone on cardiovascular prognosis. Telomere maintenance variants (e.g., rs12696304 in TERC) may compound with 9p21.3 for longevity risk when both results are available.